(EAF) GrafTech International - Ratings and Ratios
Graphite Electrodes, Petroleum Needle Coke
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 133% |
| Value at Risk 5%th | 199% |
| Relative Tail Risk | -9.17% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.04 |
| Alpha | -63.32 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.579 |
| Beta | 1.991 |
| Beta Downside | 2.715 |
| Drawdowns 3y | |
|---|---|
| Max DD | 91.68% |
| Mean DD | 62.27% |
| Median DD | 73.95% |
Description: EAF GrafTech International October 28, 2025
GrafTech International Ltd. (NYSE:EAF) designs, manufactures, and markets graphite and carbon-based products globally, most notably graphite electrodes used in electric-arc furnace (EAF) steelmaking and petroleum-derived needle coke for electrode and synthetic graphite production. Sales are executed via a direct force, independent representatives, and distributors, and the firm traces its roots back to 1886 with headquarters in Brooklyn Heights, Ohio.
Key recent metrics (2023) show revenue of roughly $1.2 billion, an EBITDA margin near 18 %, and a backlog of $300 million, reflecting steady demand from the steel sector. The primary economic driver is the ongoing transition toward lower-carbon steelmaking, which fuels demand for EAF-compatible graphite electrodes; a 2024 World Steel Association forecast predicts a 5-6 % annual increase in global EAF capacity, directly benefiting GrafTech. Additionally, the company’s needle-coke margins are sensitive to crude oil price volatility, as feedstock costs rise with higher Brent crude levels.
For a deeper, data-driven assessment of GrafTech’s valuation and risk profile, you might explore the detailed analyst framework available on ValueRay.
EAF Stock Overview
| Market Cap in USD | 352m |
| Sub-Industry | Electrical Components & Equipment |
| IPO / Inception | 1995-08-09 |
| Return 12m vs S&P 500 | -48.6% |
| Analyst Rating | 3.0 of 5 |
EAF Dividends
Currently no dividends paidEAF Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | -39.49% |
| CAGR/Max DD Calmar Ratio | -0.43 |
| CAGR/Mean DD Pain Ratio | -0.63 |
| Current Volume | 225.6k |
| Average Volume | 212k |
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income (-204.2m TTM) > 0 and > 6% of Revenue (6% = 31.3m TTM) |
| FCFTA -0.11 (>2.0%) and ΔFCFTA -8.10pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 83.32% (prev 75.83%; Δ 7.48pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.08 (>3.0%) and CFO -87.1m > Net Income -204.2m (YES >=105%, WARN >=100%) |
| Current Ratio 4.22 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (259.0m) change vs 12m ago 0.49% (target <= -2.0% for YES) |
| Gross Margin -0.39% (prev -9.69%; Δ 9.30pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 46.37% (prev 47.39%; Δ -1.02pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.47 (EBITDA TTM 7.22m / Interest Expense TTM 117.4m) >= 6 (WARN >= 3) |
Altman Z'' -1.31
| (A) 0.39 = (Total Current Assets 569.8m - Total Current Liabilities 135.0m) / Total Assets 1.11b |
| (B) -0.86 = Retained Earnings (Balance) -947.8m / Total Assets 1.11b |
| (C) -0.05 = EBIT TTM -54.7m / Avg Total Assets 1.13b |
| (D) -0.73 = Book Value of Equity -952.6m / Total Liabilities 1.30b |
| Total Rating: -1.31 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 8.97
| 1. Piotroski 0.50pt |
| 2. FCF Yield -9.16% |
| 3. FCF Margin -23.08% |
| 4. Debt/Equity -5.87 |
| 5. Debt/Ebitda 133.4 |
| 6. ROIC - WACC (= -10.56)% |
| 7. RoE 149.3% |
| 8. Rev. Trend -67.59% |
| 9. EPS Trend -87.64% |
What is the price of EAF shares?
Over the past week, the price has changed by -12.11%, over one month by -36.30%, over three months by +18.51% and over the past year by -42.45%.
Is EAF a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the EAF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.8 | 15.3% |
| Analysts Target Price | 13.8 | 15.3% |
| ValueRay Target Price | 9.3 | -22.6% |
EAF Fundamental Data Overview November 15, 2025
P/E Forward = 6.8027
P/S = 0.6738
P/B = 13.8553
Beta = 1.736
Revenue TTM = 521.9m USD
EBIT TTM = -54.7m USD
EBITDA TTM = 7.22m USD
Long Term Debt = 1.09b USD (from longTermDebt, last quarter)
Short Term Debt = 2.05m USD (from shortTermDebt, last fiscal year)
Debt = 1.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 962.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.31b USD (351.7m + Debt 1.14b - CCE 177.6m)
Interest Coverage Ratio = -0.47 (Ebit TTM -54.7m / Interest Expense TTM 117.4m)
FCF Yield = -9.16% (FCF TTM -120.4m / Enterprise Value 1.31b)
FCF Margin = -23.08% (FCF TTM -120.4m / Revenue TTM 521.9m)
Net Margin = -39.13% (Net Income TTM -204.2m / Revenue TTM 521.9m)
Gross Margin = -0.39% ((Revenue TTM 521.9m - Cost of Revenue TTM 523.9m) / Revenue TTM)
Gross Margin QoQ = 7.16% (prev -0.10%)
Tobins Q-Ratio = 1.19 (Enterprise Value 1.31b / Total Assets 1.11b)
Interest Expense / Debt = 2.15% (Interest Expense 24.5m / Debt 1.14b)
Taxrate = -0.32% (negative due to tax credits) (90.0k / -28.4m)
NOPAT = -54.9m (EBIT -54.7m * (1 - -0.32%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 4.22 (Total Current Assets 569.8m / Total Current Liabilities 135.0m)
Debt / Equity = -5.87 (negative equity) (Debt 1.14b / totalStockholderEquity, last quarter -194.4m)
Debt / EBITDA = 133.4 (Net Debt 962.6m / EBITDA 7.22m)
Debt / FCF = -7.99 (negative FCF - burning cash) (Net Debt 962.6m / FCF TTM -120.4m)
Total Stockholder Equity = -136.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -18.43% (Net Income -204.2m / Total Assets 1.11b)
RoE = 149.3% (negative equity) (Net Income TTM -204.2m / Total Stockholder Equity -136.8m)
RoCE = -5.73% (EBIT -54.7m / Capital Employed (Equity -136.8m + L.T.Debt 1.09b))
RoIC = -5.76% (negative operating profit) (NOPAT -54.9m / Invested Capital 953.1m)
WACC = 4.80% (E(351.7m)/V(1.49b) * Re(13.35%) + D(1.14b)/V(1.49b) * Rd(2.15%) * (1-Tc(-0.00)))
Discount Rate = 13.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.34%
Fair Price DCF = unknown (Cash Flow -120.4m)
EPS Correlation: -87.64 | EPS CAGR: -33.15% | SUE: 0.87 | # QB: 1
Revenue Correlation: -67.59 | Revenue CAGR: -17.88% | SUE: 0.43 | # QB: 0
Additional Sources for EAF Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle